These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11930210)

  • 1. [Inhibition of platelet function by L-arginine.L-aspartate salt].
    Wang YY; Wang JY; Fu YL; Wang C; Peng SQ
    Sheng Li Xue Bao; 2001 Aug; 53(4):303-6. PubMed ID: 11930210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet aggregation by polyaspartoyl L-arginine and its mechanism.
    Wang YY; Tang ZY; Dong M; Liu XY; Peng SQ
    Acta Pharmacol Sin; 2004 Apr; 25(4):469-73. PubMed ID: 15066215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.
    Chen YY; Kwan CY; Hui SC
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):105-8. PubMed ID: 9772654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis.
    Xuan B; Wang W; Li DX
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):133-5. PubMed ID: 8010106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle.
    Lu N; Zhan M; Gao C; Wu G; Zhang H
    Thromb Res; 2012 Oct; 130(4):e209-15. PubMed ID: 22909828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyaspartoyl.l-arginine inhibits platelet aggregation through stimulation of NO release from endothelial cells.
    Tang Z; Zhao M; Li C; Wang Y; Peng S
    Eur J Pharmacol; 2008 Jun; 588(1):41-6. PubMed ID: 18457831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
    Xu HL; Feng YP
    Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet activity of inositol hexaphosphate (IP6).
    Vucenik I; Podczasy JJ; Shamsuddin AM
    Anticancer Res; 1999; 19(5A):3689-93. PubMed ID: 10625941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MK-447 on platelet shape change, aggregation, and ATP release by collagen, ADP, and stable analogue of thromboxane A2 in rabbit platelets.
    Li BY; Zhou H; Qiao GF; Wang L; Li WH
    Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):627-30. PubMed ID: 10678127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of acetylsalvianolic acid A on platelet function].
    Yu WG; Xu LN
    Yao Xue Xue Bao; 1994; 29(6):412-6. PubMed ID: 7992621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
    Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
    Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of starfish sterol on platelet aggregation].
    Xu D; Xu S
    Zhong Yao Cai; 2000 Oct; 23(10):627-30. PubMed ID: 12575041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-HT released from platelets on thrombin-induced aggregation and ATP release in rabbit platelets in vitro.
    Li BY; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):383-6. PubMed ID: 10375791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies with the stabilized epoprostenol analogue taprostene. Effect on platelets and erythrocytes.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Jul; 40(7):817-22. PubMed ID: 2222558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-arginine load on platelet aggregation: a comparison between normotensive and preeclamptic pregnant women.
    Facchinetti F; Neri I; Piccinini F; Marietta M; Torelli U; Bruschettini PL; Volpe A
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):515-9. PubMed ID: 10376861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
    Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
    J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.